HY209

DRUG2 trials

Sponsors

Shaperon

Conditions

Atopic DermatitisSepsis

Phase 1

A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis

CompletedNCT03492398

ShaperonAtopic Dermatitis

Start: 2018-01-29End: 2019-05-28Updated: 2021-01-29

A Study of HY209 in Healthy Male Volunteers for Sepsis

CompletedNCT04255979

Start: 2019-12-05End: 2020-06-12Updated: 2020-11-30